Dartmouth-Hitchcock Medical Center
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Dartmouth-Hitchcock Medical Center sits in the top decile of US sponsors by registered trial count (#85 of 15,742 sponsors by registered trial count).
Dartmouth-Hitchcock Medical Center: 427 sponsored US clinical trials, 52 recruiting.
Dartmouth-Hitchcock Medical Center sponsors 427 registered US clinical trials on ClinicalTrials.gov, 52 of them currently recruiting, and 300 completed. 25 of these trials are in Phase 3-4 (later-stage) and 84 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Breast Cancer, with 12 trials.
Top-decile sponsor footprint
Dartmouth-Hitchcock Medical Center ranks in the top decile of sponsors by registered trial count (#85 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
300 of 352 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
427 total, page 7 of 9
Efficacy of Inhaling Bronchodilator Medications in Chronic Obstructive Pulmonary Disease
NCT01391559
Does a Daily Iron Tablet Improve Anemia in Cystic Fibrosis
NCT01755455
Effect of Ketoconazole on Breathlessness
NCT01378520
Electronic Decision Support Systems for Smokers With Severe Mental Illness
NCT01412866
Effect of Sorafenib or Regorafenib on P63 Expression and Keratinocyte Differentiation in Human Skin
NCT01466504
Integrated Cognitive Behavioral Therapy (ICBT) for Posttraumatic Stress Disorder (PTSD) and Substance Use Disorders
NCT01457404
Cognitive Behavioral Therapy (CBT) for Posttraumatic Stress Disorder (PTSD) in Community Addiction Treatment
NCT01457391
Helping Patients With Spinal Stenosis Make a Treatment Decision: A Randomized Study Assessing The Benefits of Health Coaching
NCT01263678
Study of Palliative Care Intervention for Advanced Cancer Patients and Their Caregivers -Educate Nurture Advise Before Life Ends (ENABLE III)
NCT01245621
Participation Restrictions in Breast Cancer Survivors
NCT01225328
Bendamustine and Rituximab Followed by 90-yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma
NCT01234766
Phase II Study of Alternating Sunitinib and Temsirolimus
NCT01517243
Establishing Standards for Normal Pancreatic EUS
NCT02868047
A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency
NCT01165541
Protocol to Obtain Blood and Bone Marrow Samples for Myeloma Research
NCT01382615
NIR Hypoxia Imaging of Breast Tumor Response to Neoadjuvant Chemotherapy in Vivo
NCT01934114
Phosphoproteomic Patterns as a Novel Biomarker for Aurora and Polo-like Kinase Inhibitors in Non-Small Cell Lung Cancer
NCT01510405
Analgesic Effects of Topical Ketamine Mouthwash in Patients Receiving Chemoradiation or Radiotherapy for Head & Neck Cancer
NCT01653327
Metronomic Therapy in Patients With Metastatic Melanoma
NCT01542255
Immune Status in Solid Organ Transplantation
NCT01070901
The Neuroeconomics of Behavioral Therapies for Adolescent Substance Abuse
NCT01093898
Exploratory Study of the Modulation of the Immune System by VEGF Blockade in Patients With Glioblastoma Multiforme (GBM)
NCT01091792
A Molecular Pharmacodynamic Dose-titration Trial of Conjugated Linoleic Acid (CLA; Clarinol®) in Patients With Advanced Solid Tumors
NCT00951158
Phyllodes Tumor Partial Breast Radiation Study
NCT01089374
Plastic vs. Covered Metal vs. Uncovered Metal Biliary Stents for the Management of Malignant Biliary Obstruction
NCT01038713
Cannabis and Schizophrenia: Self-Medication and Agonist Treatment
NCT00946348
Bevacizumab (Avastin) in Unresectable/Recurrent Hemangioblastoma From Von-Hippel-Lindau Disease
NCT01015300
Individually Based Psychosocial Rehabilitation for Older People With Serious Mental Illness (SMI)
NCT00817154
Microelectrodes in Epilepsy
NCT05200455
Evaluation of A Statewide Program to Prevent Early Mortality and to Promote Fitness in Persons With SMI
NCT02334280
A Study to Evaluate the Use of Supine MRI Images in Breast Conserving Surgery
NCT01929395
Role of Endorphins in Perception of Dyspnea With Resistive Loading in Chronic Obstructive Pulmonary Disease (COPD)
NCT00958919
Proof of Principle Trial to Determine if Nutritional Supplement Conjugated Linoleic Acid (CLA) Can Modulate the Lipogenic Pathway in Breast Cancer Tissue
NCT00908791
Protocol to Distinguish Tumor Recurrence From Treatment-Related Necrosis in Patients With High Grade Gliomas
NCT00942760
Protocol to Obtain Blood Samples for Leukemia Research
NCT00889031
A Clinical Trial to Validate Molecular Targets of Vorinostat in Patients With Aerodigestive Tract Cancer
NCT00735826
Harmonic Scalpel Vs. Electrocautery in Breast Reduction Surgery
NCT00819260
Digital Breast Tomosynthesis Versus Contrast Enhanced Magnetic Resonance Imaging (MRI) for Breast Cancer Staging
NCT01060085
Bevacizumab, Autologous Tumor/DC Vaccine, IL-2 and IFNα-2b in Metastatic Renal Cell Carcinoma (RCC) Patients
NCT00913913
Randomized ActiveStep Clinical Evaluation
NCT00810082
Development and Efficacy Test of Computerized Treatment for Marijuana Dependence
NCT00594659
Effect of Bronchodilation on Cycle vs Treadmill Exercise Endurance Time in COPD
NCT00754546
Cognitive Behavioral Treatment for Post-Traumatic Stress Disorder in People With Additional Serious Mental Illnesses
NCT00494650
Study of Lenalidomide as a Treatment for Neuropathy Associated With Monoclonal Gammopathy of Undetermined Significance
NCT00665652
Higher Infused Lymphocyte Counts Improve Antibody Response to Immunization After Autologous Stem Cell Transplantation
NCT00889278
Evaluation of Body-worn Multimodal Hand Hygiene System. Impact on Health-Care Associated Infections
NCT01050608
Treatment for Adolescent Marijuana Abuse
NCT00580671
Minimally Invasive Knee Replacement Outcomes (MIKRO) Study
NCT00633113
Effects of Lubiprostone on Gastric Function in Patients With Chronic Idiopathic Constipation
NCT01460225
Family Based Contingency Management for Adolescent Alcohol Abuse
NCT00595478
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 44 |
| Phase 2 | 40 |
| Phase 3 | 6 |
| Phase 4 | 19 |
Therapeutic Areas
What is open in the Dartmouth-Hitchcock Medical Center pipeline
52 recruiting of 427 indexed (12% open); 300 completed (70%).
Phase mix: 25 late (III/IV) vs 84 early (I/II) (early-phase heavy).
Top condition: Breast Cancer (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Dartmouth-Hitchcock Medical Center: open-pipeline peers nationwide
Peers matched on 427 registered trials and 12% open enrollment, not the therapeutic-area sidebar.
Dartmouth-Hitchcock Medical Center sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 427 trials (± recruiting share)
- University of Illinois at Chicago · 430 trials · 27% recruiting
- Vanderbilt University · 430 trials · 3% recruiting
- Children's Hospital of Philadelphia · 431 trials · 18% recruiting
- Novo Nordisk A/S · 431 trials · 8% recruiting
Sponsors near 12% open enrollment (± trial volume)
- Friends Research Institute · 12% recruiting · 41 trials
- Antonios Likourezos · 12% recruiting · 33 trials
- Oregon State University · 12% recruiting · 33 trials
- University of Massachusetts, Amherst · 12% recruiting · 33 trials
Related
What to do with this Dartmouth-Hitchcock Medical Center page
427 registered trials is a research-attention snapshot, not an endorsement of Dartmouth-Hitchcock Medical Center or any single study.
- 52 of Dartmouth-Hitchcock Medical Center's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Breast Cancer is the condition Dartmouth-Hitchcock Medical Center studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Breast Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Dartmouth-Hitchcock Medical Center pipeline card: 427 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.